Experts offered perspectives on how symptoms of rheumatic disease, such as fatigue, affect the physical, cognitive and emotional health of patients and offered solutions.
Search results for: hospital
ACR Honors Distinguished Fellows: Class of 2024
At ACR Convergence 2024, the ACR honored clinical and research fellows in programs from New York to California and points between.
The 2024 ACR Awards of Distinction
The 2024 ACR Awards of Distinction honor members for their outstanding contributions to the field of rheumatology.
Environmental Threats in Rheumatic Disease
Rheumatic diseases are intrinsically linked to environmental conditions. With a constantly changing environment, how can rheumatologists adapt to the challenges of global climate change, pollution and other environmental threats? The Environment + Genetics Tamiko Katsumoto, MD, a clinical associate professor in the Division of Immunology and Rheumatology at Stanford University, Palo Alto, Calif., emphasizes the…
In Memoriam: Remembering Dr. Arthur Grayzel
Dr. Arthur Grayzel leaves behind a legacy of care as a parent, teacher, researcher & clinician.
Can Primary Care Physicians Help Rheumatology’s Workforce Shortages?
In an effort to ameliorate serious rheumatology provider shortages, the ACR Workforce Solutions Committee has developed a new resource for primary care providers who treat patients with rheumatic conditions.
Updates in Ultrasound for Rheumatology 2024
It’s an exciting time for ultrasound in rheumatology, & it’s never too late to learn. Whether you’re just starting fellowship or have been practicing for decades, there’s a place for ultrasound in your practice.
How 1 Rheumatology Patient Changed the History of a Disease
The story of one patient whose research participation helped establish VEXAS as a diagnosable condition.
Young Adults with Psoriatic Disease at Risk of Early Cardiovascular Disease
Background/Purpose Psoriasis and psoriatic arthritis (PsA) are closely linked inflammatory conditions that can affect both children and adults. In children, these diseases are associated with traditional cardiovascular disease risk factors and subclinical atherosclerosis. In older adults, systemic inflammation from psoriasis and PsA accelerates atherosclerosis, and these conditions are independent risk factors for severe cardiovascular disease…
Sonelokimab Promising for Patients with PsA
A phase 2 clinical trial has demonstrated the effectiveness for multiple doses of subcutaneous sonelokimab for the treatment of adults with active psoriatic arthritis.
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 318
- Next Page »